The substances we ingest can alternatively sustain us or cause sickness. Recently, I explored how dietary habits impacts the risk of colon cancer. But what about agricultural practices?
Across the planet, we are witnessing the expansion of cheap meat, primarily fueled by demand from a growing affluent population that finally can afford beef, pork and chicken, items that were once unaffordable. Approximately 45% of increased worldwide demand is occurring in nations with rising economies such as China, India, Brazil, Indonesia and the Philippines. Poultry is expected to capture an greater portion of that growth, estimated to increase by 21% by 2034, because it is more affordable, widely acceptable and needs less input per kilogram than red meat. By 2034, it is projected that poultry will provide 45% of the protein eaten from animal-based foods.
However this comes with consequences. With scarce acreage and tight schedules, the approach in many countries has been to employ antimicrobials extensively. This isn’t just to treat illness but additionally as a preventative measure to prevent disease in overpopulated environments. Furthermore, giving antibiotics makes farm animals to grow faster, even though scientists do not know exactly why. This situation means that, in contrast to their application in people—where antibiotics are typically prescribed to combat infection—their application in agriculture is much more widespread and uncontrolled. Research monitoring their consumption estimate that 73% of all antibiotics sold globally are used in animals raised for food.
This massive misuse is causing a increase in drug-resistant bacteria. For example, colistin resistance, a “last-resort antibiotic”, initially emerged in E. coli microorganisms that subsequently infected pigs. E coli was later found in swine handlers. Only required are aeroplanes and global travel networks for these pathogens to circulate worldwide. And now, resistant strains have been identified not only in hospitals in China but around the globe.
What does this mean for someone waiting in a GP clinic or a medical center in England or Scotland? It signifies that bacterial illnesses that were once simple to cure—such as ear infections, urinary tract infections or post-operative infections—become untreatable even after a course of antimicrobials. It implies that operations such as caesarean sections, joint surgeries and cancer therapies that rely on immune suppression all become more dangerous. And while new antibiotics are technically possible to create, the development process is slow and expensive. We must preserve the tools we have.
The solutions to this problem can only come from changing global food production. Admittedly, the United Kingdom has achieved notable reductions in reducing antimicrobial use in livestock. Distribution of veterinary antimicrobials destined for consumption has declined by 59% since 2014. The application of colistin is now effectively zero. The employment of highest-priority antimicrobials has fallen to under 0.5% of all animal antibiotic sales. Moreover, research by several EU bodies indicated that after antimicrobial consumption in agriculture was reduced by almost 50% between 2014 and 2021, antimicrobial resistance in E. coli bacteria across the bloc also began to decline.
But just concentrating on the United Kingdom or Europe is a minor effort. If the major emerging economies are included in discussions on how animal protein is produced, we continue to be just as susceptible to antibiotic resistance. The difficulty is that moving towards alternative farming methods takes more space and time: making meat even more expensive in countries with large populations can quickly trigger social unrest, governmental opposition and discontent. The medical necessity is evident, but this must be weighed with concerns over nutritional access, economics and consumer expectations.
Environmental researchers have repeatedly cautioned about the environmental costs of the present worldwide agricultural model, whether it’s greenhouse gases, biodiversity loss, or deforestation. But these effects often feel long-term and abstract, particularly for people struggling with financial strain or worried about short-term medical services.
Antibiotic resistance is concrete. Virtually all people has taken antibiotics at some point, and we can imagine what would happen if their curative power was abruptly lost. Agriculture, medicine and climate are all interlinked. How pig meat is produced in Asia affects whether your child’s antibiotics are effective in Edinburgh. Whether a woman in Lagos survives a C-section is linked to how chickens are farmed in Brazil.
If we address these pervasive, world-spanning challenges, such as how our diet is sourced and how we use our current medications, we endanger something precious: the capacity to treat infections that we assume will always work today.